Nexlizet recall: Failed Dissolution
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108…
Why was Nexlizet recalled?
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #, 1990305, Exp 08-31-2025
- Product
- NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108…
- Recalling firm
- Esperion
- Quantity
- 3,480 30-count bottles
- Distribution
- Nationwide in the USA
- Recall date
- April 24, 2024
- Classification
- Class III
- Status
- Completed
- Agency
- FDA (drug)